Enveric Biosciences (ENVB) had the highest return in Q3 2009 by a US stock, returning 844.4%.

ASSET	QUARTER	% RETURN
Enveric Biosciences (ENVB)	Q3 2009	844.44%
Gyre Therapeutics (GYRE)	Q3 2009	754.8%
Applied Digital (APLD)	Q3 2009	702.47%
TherapeuticsMD (TXMD)	Q3 2009	652.94%
FitLife Brands, Inc Common Stock (FTLF)	Q3 2009	600%
Mercer International (MERC)	Q3 2009	484.42%
Sleep Number (SNBR)	Q3 2009	452.33%
Comstock Holding Companies (CHCI)	Q3 2009	423.17%
Dana (DAN)	Q3 2009	404.41%
Xpel (XPEL)	Q3 2009	400%
Lee Enterprises (LEE)	Q3 2009	388.45%
Perspective Therapeutics (CATX)	Q3 2009	378.26%
Gray Television (GTN)	Q3 2009	373.46%
Aura Minerals Inc Common Shares (AUGO)	Q3 2009	371.58%
Commercial Vehicle (CVGI)	Q3 2009	339.86%
Nexstar Broadcasting (NXST)	Q3 2009	338.46%
Entravision Communications (EVC)	Q3 2009	332.66%
CEL-SCI (CVM)	Q3 2009	300%
Wabash National (WNC)	Q3 2009	277.74%
Radian (RDN)	Q3 2009	272.64%
Gray Television (GTN.A)	Q3 2009	262.52%
Urban One Inc Class D (UONEK)	Q3 2009	251.25%
Tegna (TGNA)	Q3 2009	251.18%
E W Scripps Co Class A (SSP)	Q3 2009	248.86%
Mitek Systems (MITK)	Q3 2009	226.67%